Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:tumor measurement
go back to main search page
Accession:CMO:0000341 term browser browse the term
Definition:Measurement of an abnormal growth of tissue resulting from uncontrolled, progressive multiplication of cells and serving no physiological function.


show annotations for term's descendants           Sort by:
 
benign colorectal tumor number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Colcr5 Colorectal carcinoma resistance QTL 5 IDA RGD PMID:17510081 RGD:1625309 NCBI chr 6:122,549,046...137,801,795 JBrowse link
Q Colcr9 Colorectal carcinoma resistance QTL 9 IDA RGD PMID:17510081 RGD:1625309 NCBI chr20:1,530,655...46,530,655 JBrowse link
benign colorectal tumor surface area measurement term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Colcr1 Colorectal carcinoma resistance QTL 1 IDA RGD PMID:17510081 RGD:1625309 NCBI chr 4:1...29,494,328 JBrowse link
Q Colcr6 Colorectal carcinoma resistance QTL 6 IDA RGD PMID:17510081 RGD:1625309 NCBI chr15:73,690,518...99,794,247 JBrowse link
Q Colcr7 Colorectal carcinoma resistance QTL 7 IDA RGD PMID:17510081 RGD:1625309 NCBI chr17:2,115,149...21,881,669 JBrowse link
Q Colcs1 Colorectal carcinoma susceptibility QTL 1 IDA RGD PMID:17510081 RGD:1625309 NCBI chr 5:121,846,814...166,846,814 JBrowse link
colorectal tumor number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Colcr2 Colorectal carcinoma resistance QTL 2 IDA RGD PMID:17510081 RGD:1625309 NCBI chr15:2,266,368...22,711,984 JBrowse link
mammary tumor growth rate term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Mamtr7 Mammary tumor resistance QTL 7 IDA RGD PMID:19052818 RGD:2302423 NCBI chr10:9,658,275...104,670,812 JBrowse link
Q Mamtr8 Mammary tumor resistance QTL 8 IDA RGD PMID:19052818 RGD:2302423 NCBI chr18:31,359,408...83,218,561 JBrowse link
Q Mcs20 Mammary carcinoma susceptibility QTL 20 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 9:13,533,770...42,791,750 JBrowse link
Q Mcs21 Mammary carcinoma susceptibility QTL 21 IDA RGD PMID:16596452 RGD:1599317 NCBI chr10:28,875,650...52,200,160 JBrowse link
Q Mcs22 Mammary carcinoma susceptibility QTL 22 IDA RGD PMID:16596452 RGD:1599317 NCBI chr18:52,539,763...63,933,058 JBrowse link
mammary tumor incidence/prevalence measurement term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Mcs31 Mammary carcinoma susceptibility QTL 31 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 9:77,813,894...111,552,878 JBrowse link
Q Mcs32 Mammary carcinoma susceptibility QTL 32 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 1:115,540,693...238,914,717 JBrowse link
Q Mcs33 Mammary carcinoma susceptibility QTL 33 IDA RGD PMID:23967281 RGD:7794780 NCBI chr 5:131,345,754...166,875,058 JBrowse link
Q Mcs34 Mammary carcinoma susceptibility QTL 34 IDA RGD PMID:23967281 RGD:7794780
mammary tumor number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca11 Estrogen-induced mammary cancer QTL 11 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:99,753,548...113,061,097 JBrowse link
Q Emca12 Estrogen-induced mammary cancer QTL 12 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:124,160,767...133,749,643 JBrowse link
Q Emca13 Estrogen-induced mammary cancer QTL 13 IDA RGD PMID:23151807 RGD:7364727 NCBI chr 5:9,823,266...99,753,708 JBrowse link
Q Emca6 Estrogen-induced mammary cancer QTL 6 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 4:44,463,720...155,883,716 JBrowse link
Q Emca7 Estrogen-induced mammary cancer QTL 7 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 6:15,107,216...107,351,382 JBrowse link
Q Emca8 Estrogen-induced mammary cancer QTL 8 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 5:50,328,551...141,643,988 JBrowse link
Q Mamtr1 Mammary tumor resistance QTL 1 IDA RGD PMID:12844486 RGD:631852 NCBI chr 5:12,789,751...113,558,310 JBrowse link
Q Mamtr2 Mammary tumor resistance QTL 2 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:7,887,772...12,654,247 JBrowse link
Q Mamtr3 Mammary tumor resistance QTL 3 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:32,373,770...43,665,178 JBrowse link
Q Mamtr4 Mammary tumor resistance QTL 4 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:16,491,740...61,491,740 JBrowse link
Q Mamtr5 Mammary tumor resistance QTL 5 IDA RGD PMID:17230524 RGD:1599390 NCBI chr 5:18,873,947...63,873,947 JBrowse link
Q Mamtr6 Mammary tumor resistance QTL 6 IDA RGD PMID:17230524 RGD:1599390 NCBI chr18:19,278,901...83,218,561 JBrowse link
Q Mcs1 Mammary carcinoma susceptibility QTL 1 IDA RGD PMID:8168109 RGD:61080 NCBI chr 2:7,887,772...23,319,447 JBrowse link
Q Mcs12 Mammary carcinoma susceptibility QTL 12 IDA RGD PMID:16266982 RGD:1559294 NCBI chr 5:58,973,449...60,051,321 JBrowse link
Q Mcs13 Mammary carcinoma susceptibility QTL 13 IDA RGD PMID:16266982 RGD:1559294 NCBI chr 5:63,190,890...69,927,503 JBrowse link
Q Mcs14 Mammary carcinoma susceptibility QTL 14 IDA RGD PMID:16266982 RGD:1559294 NCBI chr 5:76,369,776...80,813,390 JBrowse link
Q Mcs15 Mammary carcinoma susceptibility QTL 15 IDA RGD PMID:16568087 RGD:1581951 NCBI chr10:85,565,469...103,884,409 JBrowse link
Q Mcs16 Mammary carcinoma susceptibility QTL 16 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:2,244,390...43,433,040 JBrowse link
Q Mcs17 Mammary carcinoma susceptibility QTL 17 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 1:197,670,404...242,670,404 JBrowse link
Q Mcs18 Mammary carcinoma susceptibility QTL 18 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 2:7,887,772...42,804,738 JBrowse link
Q Mcs19 Mammary carcinoma susceptibility QTL 19 IDA RGD PMID:16596452 RGD:1599317 NCBI chr 5:99,485,997...103,690,167 JBrowse link
Q Mcs2 Mammary carcinoma susceptibility QTL 2 IDA RGD PMID:9584103 RGD:61081 NCBI chr 7:19,032,807...35,526,300 JBrowse link
Q Mcs23 Mammary carcinoma susceptibility QTL 23 IDA RGD PMID:17404222 RGD:1601189
Q Mcs24 Mammary carcinoma susceptibility QTL 24 IDA RGD PMID:17404222 RGD:1601189 NCBI chr 5:64,719,390...109,719,390 JBrowse link
Q Mcs28 Mammary carcinoma susceptibility QTL 28 IDA RGD PMID:21205740 RGD:5684388 NCBI chr 5:77,743,239...78,039,084 JBrowse link
Q Mcs29 Mammary carcinoma susceptibility QTL 29 IDA RGD PMID:21205740 RGD:5684388 NCBI chr 5:77,816,155...77,988,860 JBrowse link
Q Mcs3 Mammary carcinoma susceptibility QTL 3 IDA RGD PMID:9584103 RGD:61081 NCBI chr 1:102,268,556...147,268,556 JBrowse link
Q Mcs30 Mammary carcinoma susceptibility QTL 30 IDA RGD PMID:24023717 RGD:7327193 NCBI chr12:797,729...8,525,593 JBrowse link
Q Mcs4 Mammary carcinoma susceptibility QTL 4 IDA RGD PMID:9584103 RGD:61081 NCBI chr 8:16,290,444...61,290,444 JBrowse link
Q Mcs5 Mammary carcinoma susceptibility QTL 5 IDA RGD PMID:11139513 RGD:62417 NCBI chr 5:55,805,606...132,207,589 JBrowse link
Q Mcs6 Mammary carcinoma susceptibility QTL 6 IDA RGD PMID:11139513 RGD:62417 NCBI chr 7:26,737,401...63,902,784 JBrowse link
Q Mcs7 Mammary carcinoma susceptibility QTL 7 IDA RGD PMID:11139513 RGD:62417 NCBI chr10:72,224,939...107,211,142 JBrowse link
Q Mcs8 Mammary carcinoma susceptibility QTL 8 IDA RGD PMID:11139513 RGD:62417 NCBI chr14:3,813,074...24,531,477 JBrowse link
Q Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 IDA RGD PMID:11139513 RGD:62417 NCBI chr 6:58,632,962...103,632,962 JBrowse link
number of squamous cell tumors of the tongue with diameter greater than 3 mm term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcas10 Tongue tumor susceptibility QTL 10 IDA RGD PMID:11429048 RGD:634723 NCBI chr10:31,297,439...76,297,439 JBrowse link
Q Tcas11 Tongue tumor susceptibility QTL 11 IDA RGD PMID:16527513 RGD:1578522 NCBI chr 5:46,711,509...161,317,411 JBrowse link
Q Tcas2 Tongue tumor susceptibility QTL 2 IDA RGD PMID:11429048 RGD:634723 NCBI chr 1:192,485,903...199,050,587 JBrowse link
Q Tcas3 Tongue tumor susceptibility QTL 3 IDA RGD PMID:11429048 RGD:634723 NCBI chr 4:10,814,170...91,360,527 JBrowse link
Q Tcas4 Tongue tumor susceptibility QTL 4 IDA RGD PMID:11429048 RGD:634723 NCBI chr14:17,622,561...42,337,007 JBrowse link
Q Tcas5 Tongue tumor susceptibility QTL 5 IDA RGD PMID:11429048 RGD:634723 NCBI chr19:9,977,753...39,654,489 JBrowse link
Q Tcas6 Tongue tumor susceptibility QTL 6 IDA RGD PMID:11429048 RGD:634723 NCBI chr 1:92,948,896...144,267,916 JBrowse link
Q Tcas8 Tongue tumor susceptibility QTL 8 IDA RGD PMID:11429048 RGD:634723
Q Tcas9 Tongue tumor susceptibility QTL 9 IDA RGD PMID:11429048 RGD:634723 NCBI chr 6:1...37,618,905 JBrowse link
number of squamous cell tumors of the tongue with diameter greater than 5 mm term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcat1 Tongue tumor resistance QTL 1 IDA RGD PMID:9563479 RGD:61091 NCBI chr 1:99,267,916...144,267,916 JBrowse link
percentage of study population developing mammary tumors during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca4 Estrogen-induced mammary cancer QTL 4 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 7:62,004,452...101,773,158 JBrowse link
Q Emca5 Estrogen-induced mammary cancer QTL 5 IDA RGD PMID:16885383 RGD:1642522 NCBI chr 3:43,827,364...169,034,231 JBrowse link
percentage of study population developing T-cell lymphomas during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tls2 T-lymphoma susceptibility QTL 2 IDA RGD PMID:10360666 RGD:619600 NCBI chr 7:80,221,299...109,401,111 JBrowse link
Q Tls3 T-lymphoma susceptibility QTL 3 IDA RGD PMID:10360666 RGD:619600 NCBI chr10:51,774,612...95,600,334 JBrowse link
percentage of study population developing testis tumors during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tescar1 Testicular tumor resistance QTL 1 IDA RGD PMID:15805257 RGD:1358944 NCBI chr11:1,041,931...66,113,562 JBrowse link
percentage of study population developing trigeminal nerve neurilemmomas during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Schws1 Schwannoma susceptibility QTL 1 IDA RGD PMID:16003739 RGD:1559300 NCBI chr10:40,035,094...102,359,817 JBrowse link
Q Schws2 Schwannoma susceptibility QTL 2 IDA RGD PMID:16003739 RGD:1559300
Q Schws3 Schwannoma susceptibility QTL 3 IDA RGD PMID:16003739 RGD:1559300 NCBI chr 3:118,839,124...163,839,124 JBrowse link
Q Schws4 Schwannoma susceptibility QTL 4 IDA RGD PMID:16003739 RGD:1559300 NCBI chr 6:83,190,345...106,747,639 JBrowse link
Q Schws7 Schwannoma susceptibility QTL 7 IDA RGD PMID:16003739 RGD:1559300 NCBI chr10:4,765,527...19,816,042 JBrowse link
Q Schws8 Schwannoma susceptibility QTL 8 IDA RGD PMID:25303613 RGD:11566050 NCBI chr 6:94,968,928...139,968,928 JBrowse link
Q Schws9 Schwannoma susceptibility QTL 9 IDA RGD PMID:25303613 RGD:11566050 NCBI chr 6:61,747,639...106,747,639 JBrowse link
poorly differentiated malignant colorectal tumor number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Colcr2 Colorectal carcinoma resistance QTL 2 IDA RGD PMID:17510081 RGD:1625309 NCBI chr15:2,266,368...22,711,984 JBrowse link
Q Colcr3 Colorectal carcinoma resistance QTL 3 IDA RGD PMID:17510081 RGD:1625309 NCBI chr18:2,249,477...22,066,430 JBrowse link
Q Colcr8 Colorectal carcinoma resistance QTL 8 IDA RGD PMID:17510081 RGD:1625309 NCBI chr18:22,066,242...52,293,055 JBrowse link
poorly differentiated malignant colorectal tumor surface area measurement term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Colcr3 Colorectal carcinoma resistance QTL 3 IDA RGD PMID:17510081 RGD:1625309 NCBI chr18:2,249,477...22,066,430 JBrowse link
post-insult time to mammary tumor formation term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca1 Estrogen-induced mammary cancer QTL 1 IDA RGD PMID:15611180 RGD:1358124 NCBI chr 5:99,216,724...148,607,142 JBrowse link
Q Emca10 Estrogen-induced mammary cancer QTL 10 IDA RGD PMID:18420736 RGD:2292503 NCBI chr 6:16,536,140...61,536,140 JBrowse link
Q Emca2 Estrogen-induced mammary cancer QTL 2 IDA RGD PMID:15611180 RGD:1358124 NCBI chr18:18,007,599...63,571,040 JBrowse link
Q Mcs26 Mammary carcinoma susceptibility QTL 26 IDA RGD PMID:20737482 RGD:4143380 NCBI chr 6:106,752,656...132,339,866 JBrowse link
Q Mcs27 Mammary carcinoma susceptibility QTL 27 IDA RGD PMID:20737482 RGD:4143380 NCBI chr13:43,437,904...47,841,255 JBrowse link
post-insult time to onset of T-cell lymphoma term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tls1 T-lymphoma susceptibility QTL 1 IDA RGD PMID:10360666 RGD:619600 NCBI chr 5:90,450,144...135,450,144 JBrowse link
post-insult time to trigeminal nerve neurilemmoma formation term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Schws5 Schwannoma susceptibility QTL 5 IDA RGD PMID:16003739 RGD:1559300
squamous cell carcinoma of the head and neck tumor number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcas7 Tongue tumor susceptibility QTL 7 IDA RGD PMID:15876484 RGD:1358147 NCBI chr19:24,817,978...39,654,489 JBrowse link
squamous cell carcinoma of the tongue maximum tumor diameter term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcas1 Tongue tumor susceptibility QTL 1 IDA RGD PMID:9563479 RGD:61091 NCBI chr19:2,316,121...47,316,121 JBrowse link
stomach tumor depth of invasion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Gcr3 Gastric cancer resistance QTL 3 IDA RGD PMID:10706129 RGD:69698 NCBI chr16:17,696,791...82,635,055 JBrowse link
stomach tumor diameter term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Gcr3 Gastric cancer resistance QTL 3 IDA RGD PMID:10706129 RGD:69698 NCBI chr16:17,696,791...82,635,055 JBrowse link
stomach tumor susceptibility score term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Gcr1 Gastric cancer resistance QTL 1 IDA RGD PMID:10706129 RGD:69698 NCBI chr 4:120,260,281...147,278,687 JBrowse link
Q Gcr2 Gastric cancer resistance QTL 2 IDA RGD PMID:10706129 RGD:69698 NCBI chr 3:8,658,162...27,494,778 JBrowse link
Q Gcs1 Gastric cancer susceptibility QTL1 IDA RGD PMID:10706129 RGD:69698 NCBI chr15:76,306,099...101,769,107 JBrowse link
well differentiated malignant colorectal tumor surface area measurement term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Colcr4 Colorectal carcinoma resistance QTL4 IDA RGD PMID:17510081 RGD:1625309 NCBI chr 6:20,338,777...62,613,667 JBrowse link
Term paths to the root